Pharmaceutical Recognition of Abacavir Sulfate, Abarelix, and Abiraterone Acetate
These substances, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess distinct chemical architectures leading to their varying pharmacological actions. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily recognized via its molecular formula – C14H15N6O4·H2SO4 – and characteristic radiant properties observed in techniques such as mass spectrometry and infrared spectroscopy. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor inhibitor, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for total identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate malignancy treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) spectroscopic data, ensuring its correct chemical characterization.
Catalogue: Abacavir Disulfate Sulfate (CAS 188062-50-2) & Associated Substances
Explore the extensive listing detailing Abacavir Disulfate Sulfate, identified by CAS number 188062-50-2, and a selection of related substances. The offering includes several levels to meet specific research and manufacturing demands. Visitors will detailed data including analytical data and existing packaging options. Besides, investigate a array of structurally cognate compounds that may be beneficial in the current project. This directory is designed to facilitate effective acquiring of high-quality pharmaceutical reagents.
Chemical Listing: Abarelix and Abiraterone Acetate Chemical Abstract Service Numbers
For scientists and drug professionals requiring precise chemical identification, correct Chemical Abstract Service identifiers are vital. Specifically, abarelix, a GnRH-releasing hormone modulator used in managing prostate tumors, is assigned the Registry number 65572-21-8. Furthermore, abiraterone acetate, a powerful medication in metastatic tumors, carries the CAS code 389292-17-3. Careful recording and verification of these Chemical Abstract Service codes are critical to ensure correct substance recognition and subsequent procedures. These numbers are publicly obtainable through various scientific resources. Frequently refer authorized data for the most details.
Drug Substances: Abacavir Sulfate , , Abiraterone Acetate, Registry Numbers
The recognition of essential pharmaceutical compounds often relies on precise chemical designations. Specifically, this article succinctly examines three important cases: Abacavir Sulfate, a drug reverse enzyme inhibitor; Abarelix, a hormone antagonist; and Abiraterone, utilized in cancer management. Each compound is connected with a unique CAS number, supplying a universal method for identifying information and ensuring accurate communication within the research field. View the respective repositories for detailed listings and connected information.
Chemical Abstracts Service Number Database: Details for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The vast Chemical Abstracts Service (CAS) database is an ANASTRAZOLE 120511-73-1 essential resource for researchers and industry professionals alike. This section briefly outlines data pertaining to three significant medicinal compounds: Abacavir Sulfate, a drug used to treat HIV; Abarelix Acetate, a antagonist employed in treatment; and Abiraterone Acetate Salt, a potent medication administered in the management of metastatic advanced cancer. Locating the accurate CAS code for each compound allows for certain identification and facilitates precise research exploration. These individual identifiers are indispensable for scientific integrity and uniform communication across the field.
Employing API Material Data: Item Identification with CAS Registry Numbers
Accurate product identification is essential in the substance industry, and API substance data provides a reliable answer. Particularly, CAS numbers act as unique identifiers for chemical entities, enabling easy integration with collections and frameworks. This kind of approach not only improves records precision but also simplifies workflows related to investigation, procurement, and regulatory submission. Furthermore, obtaining this data via an Web API promotes automation and lessens the potential for human error.